• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,664.21 -999.79
( -1.29%)
Global Indices
Nasdaq
49,249.13 -82.20
(-0.17%)
Dow Jones
7,185.72 56.32
(0.79%)
Hang Seng
59,744.07 603.84
(1.02%)
Nikkei 225
10,387.94 -69.07
(-0.66%)
Forex
USD-INR
94.05 0.29
(0.31%)
EUR-INR
109.99 0.01
(0.01%)
GBP-INR
126.84 0.17
(0.14%)
JPY-INR
0.59 0.00
(0.16%)

EQUITY - MARKET SCREENER

Johnson Pharmacare Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
532154
INE560F01022
1.0202255
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
31.9
EPS(TTM)
Face Value()
Div & Yield %
0
1
0
 

Concord Control Systems bags Rs 54-cr KAVACH 4.0 order from Indian Railways
Feb 28,2026

The contract covers the supply, installation, testing and commissioning of onboard KAVACH 4.0 equipment.

The company confirmed that promoters and group companies have no interest in the awarding entity, and the order does not qualify as a related party transaction.

Concord Control Systems is India's leading manufacturer of embedded electronics systems and critical electronic solutions supporting India’s next-generation rail infrastructure. The company is an RDSO-approved OEM and technology leader delivering advanced electrical and electronic systems for Indian Railways.

On a consolidated basis, the company had reported 93.48% jump in net profit to Rs 16.02 crore on a 63.92% increase in revenue to Rs 81.55 crore in H1 FY26 over H1 FY25.

Shares of Concord Control Systems added 1.58% to end at Rs 2,435 on the BSE.